FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2069659635> ?p ?o ?g. }

• W2069659635 endingPage "466" @default.
• W2069659635 startingPage "457" @default.
• W2069659635 abstract "To identify a group of patients who might benefit from the addition of weekly paclitaxel to conventional anthracycline-containing chemotherapy as adjuvant therapy of node-positive operable breast cancer. The predictive value of PAM50 subtypes and the 11-gene proliferation score contained within the PAM50 assay were evaluated in 820 patients from the GEICAM/9906 randomized phase III trial comparing adjuvant FEC to FEC followed by weekly paclitaxel (FEC-P). Multivariable Cox regression analyses of the secondary endpoint of overall survival (OS) were performed to determine the significance of the interaction between treatment and the (1) PAM50 subtypes, (2) PAM50 proliferation score, and (3) clinical and pathological variables. Similar OS analyses were performed in 222 patients treated with weekly paclitaxel versus paclitaxel every 3 weeks in the CALGB/9342 and 9840 metastatic clinical trials. In GEICAM/9906, with a median follow up of 8.7 years, OS of the FEC-P arm was significantly superior compared to the FEC arm (unadjusted HR = 0.693, p = 0.013). A benefit from paclitaxel was only observed in the group of patients with a low PAM50 proliferation score (unadjusted HR = 0.23, p < 0.001; and interaction test, p = 0.006). No significant interactions between treatment and the PAM50 subtypes or the various clinical–pathological variables, including Ki-67 and histologic grade, were identified. Finally, similar OS results were obtained in the CALGB data set, although the interaction test did not reach statistical significance (p = 0.109). The PAM50 proliferation score identifies a subset of patients with a low proliferation status that may derive a larger benefit from weekly paclitaxel." @default.
• W2069659635 created "2016-06-24" @default.
• W2069659635 creator A5002051538 @default.
• W2069659635 creator A5012979471 @default.
• W2069659635 creator A5016816358 @default.
• W2069659635 creator A5017224474 @default.
• W2069659635 creator A5018612347 @default.
• W2069659635 creator A5018682396 @default.
• W2069659635 creator A5019935261 @default.
• W2069659635 creator A5021488024 @default.
• W2069659635 creator A5021514634 @default.
• W2069659635 creator A5022854192 @default.
• W2069659635 creator A5026298654 @default.
• W2069659635 creator A5035054317 @default.
• W2069659635 creator A5035102028 @default.
• W2069659635 creator A5039927103 @default.
• W2069659635 creator A5040177206 @default.
• W2069659635 creator A5043353796 @default.
• W2069659635 creator A5045301167 @default.
• W2069659635 creator A5047713528 @default.
• W2069659635 creator A5057135409 @default.
• W2069659635 creator A5069723692 @default.
• W2069659635 creator A5070245248 @default.
• W2069659635 creator A5071202334 @default.
• W2069659635 creator A5073571977 @default.
• W2069659635 creator A5075937719 @default.
• W2069659635 creator A5078161203 @default.
• W2069659635 creator A5080310093 @default.
• W2069659635 creator A5089513581 @default.
• W2069659635 date "2013-02-20" @default.
• W2069659635 modified "2023-10-18" @default.
• W2069659635 title "PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer" @default.
• W2069659635 cites W1815740577 @default.
• W2069659635 cites W1972595386 @default.
• W2069659635 cites W1978291661 @default.
• W2069659635 cites W1984562552 @default.
• W2069659635 cites W1985961433 @default.
• W2069659635 cites W1990371044 @default.
• W2069659635 cites W2001133390 @default.
• W2069659635 cites W2009740420 @default.
• W2069659635 cites W2015921398 @default.
• W2069659635 cites W2033799417 @default.
• W2069659635 cites W2037834300 @default.
• W2069659635 cites W2069550311 @default.
• W2069659635 cites W2081319583 @default.
• W2069659635 cites W2083907066 @default.
• W2069659635 cites W2091205535 @default.
• W2069659635 cites W2103321886 @default.
• W2069659635 cites W2103988568 @default.
• W2069659635 cites W2105882193 @default.
• W2069659635 cites W2109637975 @default.
• W2069659635 cites W2113344831 @default.
• W2069659635 cites W2113435829 @default.
• W2069659635 cites W2113499049 @default.
• W2069659635 cites W2117151785 @default.
• W2069659635 cites W2117239059 @default.
• W2069659635 cites W2118413367 @default.
• W2069659635 cites W2123528875 @default.
• W2069659635 cites W2132619562 @default.
• W2069659635 cites W2136655134 @default.
• W2069659635 cites W2136791645 @default.
• W2069659635 cites W2138659386 @default.
• W2069659635 cites W2143989581 @default.
• W2069659635 cites W2145621820 @default.
• W2069659635 cites W2152590519 @default.
• W2069659635 cites W2156273110 @default.
• W2069659635 cites W2157050561 @default.
• W2069659635 cites W2160377567 @default.
• W2069659635 cites W2160450758 @default.
• W2069659635 cites W2161109798 @default.
• W2069659635 cites W2163563958 @default.
• W2069659635 cites W2163814095 @default.
• W2069659635 cites W2164839546 @default.
• W2069659635 cites W2168125854 @default.
• W2069659635 doi "https://doi.org/10.1007/s10549-013-2416-2" @default.
• W2069659635 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3608881" @default.
• W2069659635 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23423445" @default.
• W2069659635 hasPublicationYear "2013" @default.
• W2069659635 type Work @default.
• W2069659635 sameAs 2069659635 @default.
• W2069659635 citedByCount "87" @default.
• W2069659635 countsByYear W20696596352013 @default.
• W2069659635 countsByYear W20696596352014 @default.
• W2069659635 countsByYear W20696596352015 @default.
• W2069659635 countsByYear W20696596352016 @default.
• W2069659635 countsByYear W20696596352017 @default.
• W2069659635 countsByYear W20696596352018 @default.
• W2069659635 countsByYear W20696596352019 @default.
• W2069659635 countsByYear W20696596352020 @default.
• W2069659635 countsByYear W20696596352021 @default.
• W2069659635 countsByYear W20696596352022 @default.
• W2069659635 countsByYear W20696596352023 @default.
• W2069659635 crossrefType "journal-article" @default.
• W2069659635 hasAuthorship W2069659635A5002051538 @default.
• W2069659635 hasAuthorship W2069659635A5012979471 @default.
• W2069659635 hasAuthorship W2069659635A5016816358 @default.
• W2069659635 hasAuthorship W2069659635A5017224474 @default.
• W2069659635 hasAuthorship W2069659635A5018612347 @default.

• next